ALLISON EISENBERG: Open Payments
NPI 1689212003 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,526 in 60 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $115 · 2025 $1,526
Food & beverage: $1,526
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $394 |
| Galderma Laboratories, L.P. | 10 | $213 |
| Almirall LLC | 5 | $123 |
| GENZYME CORPORATION | 4 | $118 |
| Novartis Pharmaceuticals Corporation | 4 | $111 |
| Incyte Corporation | 4 | $105 |
| UCB, Inc. | 3 | $79 |
| REVANCE THERAPEUTICS, INC. | 1 | $75 |
| PFIZER INC. | 2 | $55 |
| Amgen Inc. | 2 | $55 |
Products named: SKYRIZI, RINVOQ, Klisyri, DUPIXENT, AKLIEF, COSENTYX, OPZELURA, NEMLUVIO.
Industry payments across NY — which companies pay providers there.
